Posts Tagged ‘Advisory Panels’

July 22nd, 2010

Lessons Learned from 2 Avandia Panels

In a perspective published online in the New England Journal of Medicine, Clifford Rosen, who was the chair of the 2007 FDA Advisory Panel that allowed rosiglitazone (Avandia) to remain on the market and also a member of the panel that met last week, writes about “lessons learned” from the extraordinary series of events involving […]